Topic
Pharmaceuticals
1,010 published works
Inside EU Life Sciences
Landmark UK-US Pharmaceutical Deal
By Grant Castle, Raj Gathani, Dan Spivey
On 1 December 2025, the UK Government announced a “landmark” UK-US pharmaceutical deal. Under the deal, the UK claims to be (so far) the only country to secure zero-percent tariffs…
International Trade Insights
The US and UK Reach Agreement in Principle on Pharmaceuticals, Pharmaceutical Ingredients, and Medical Technology
On December 1, 2025, the United States and United Kingdom announced an agreement in principal on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under the agreement, the U.S. will: Exempt U.K.-origin…
Regulatory Oversight
Fourth Circuit Revives West Virginia Public Nuisance Suit Against Opioid Distributors
By Barry Boise, Jeff Johnson, Jessica Birdsong, Lauren Fincher
What Happened: A unanimous panel of the U.S. Court of Appeals for the Fourth Circuit revived a suit against certain pharmaceutical distributors brought under West Virginia public nuisance law. The…
As Prescribed
Major Overhaul of UK Rare Disease Regulation: MHRA Proposes Enhanced Framework
By Morgan Lewis
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced its intention to introduce sweeping reforms for accelerating rare disease therapy development and approval, with the aim to position…
Drug Injury Watch
Wegovy and Ozempic Increase NAION Risk, an Eye Side Effect That Can Result in Blindness
By Tom Lamb
Semaglutide is the Active Ingredient in These GLP-1 Drugs Used for Diabetes or Weight Loss (Posted by Tom Lamb at Drug Injury Watch) Over the past year, we have written several articles that…
TortsProf Blog
Meier on Failure-to-Warn Suits Against Pharmaceutical Companies
Luke Meier has posted to SSRN Failure-to-Warn Suits Against Pharmaceutical Companies: Physician Testimony, Causation, and Summary Judgment. The abstract provides: It is hard to win a tort suit against a…
Global Supply Chain Compliance
Healthcare & Life Sciences Supply Chains Series: Achieving Stability Through Innovation and Compliance (3 of 4)
By Publisher
As supply chains shift and vendor arrangements evolve in response to tariffs, life sciences companies must adapt to increasingly intricate and intertwined challenges across operational and commercial needs. Manufacturing relocation,…
Global Policy Watch
Germany enacts Standard Contractual Clauses for pharmaceutical clinical trial agreements – Changes for medical device studies also on the horizon
By Dr. Dr. Adem Koyuncu, Maximilian Aretz
Germany has taken another step to improve the conditions for pharmaceutical research & development in Germany. Now, the Federal Government has adopted the “Standard Contractual Clauses” for pharmaceutical clinical trial…
Delaware Corporate & Commercial Litigation Blog
Chancery Court lets bankruptcy admin press suit against ex-pharma D&Os
Frank Reynolds, who has been covering Delaware corporate decisions for various national publications for over 40 years, prepared this article. The Court of Chancery recently refused to dismiss most of…
Elder Law Prof Blog
Recent News Articles for Law Students to Consider When Looking for Legal Research Topics with Significance in an Aging World
It is the time of year when law students often stop by my office for a visit to explore possible ideas for their case notes for law review or for…